Post-earnings recap
Reported
Mon, May 12, 2025
EPS actual
$-0.36
EPS est.
$-0.34
EPS surprise
-4.96%
1-day move
+14.91%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Despite missing on EPS, Tango Therapeutics I saw a significant stock increase of 14.91%. This positive reaction may be attributed to management's optimistic outlook on their research pipeline and future projects, which investors found encouraging.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.36 | N/A | -4.96% |
| Revenue | N/A | N/A | N/A |
Management remains focused on advancing their therapeutic developments. They acknowledged the EPS results but emphasized long-term goals.
Management expressed confidence in ongoing projects and future developments.
They highlighted the importance of their research pipeline despite the EPS miss.